Новые возможности в комбинированной терапии папилломавирусной инфекции
Л. С. Осипова, A.A. Sukhanova, Е. Ю. Соколова · Zenodo (CERN European Organization for Nuclear Research) · 2018
The article presents the results of studying the eff ectiveness and experience with antiviral and immunomodulating drug Groprinozin (inosine pranobex) in treatment of human papillomavirus infection in women. The results of immunological studies. Based on the studies found that the inclusion of Groprinozin in the complex therapy of these patients contributes to immunological reactivity, improve the clinical course of the disease, a signifi cant reduction in relapses.
Cited by 0 works. doi:10.18370/2309-4117.2018.39.68-75 Open-access PDF
Authors
References
- The epidemiology of human papillomavirus infections
- Human papillomavirus immortalization and transformation functions
- Epidemiology of Cervical Human Papillomavirus Infections
- Management of genital warts.
- An Rb-Skp2-p27 Pathway Mediates Acute Cell Cycle Inhibition by Rb and Is Retained in a Partial-Penetrance Rb Mutant
- A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions
- Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study.
- Oral proliferative verrucous leukoplakia (PVL); open trial of surgery compared with combined therapy using surgery and methisoprinol in papillomavirus-related PVL
- Immunotherapy of genital warts with inosine pranobex and conventional treatment: double blind placebo controlled study.
- High- and Intermediate-Risk Human Papillomavirus Infection in Sexually Active Adolescent Females